CWS Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$697K Buy
758
+265
+54% +$269K 0.18% 76
2025
Q4
$530K Sell
493
-49
-9% -$46.9K 0.14% 89
2025
Q3
$414K Sell
542
-177
-25% -$132K 0.11% 99
2025
Q2
$561K Hold
719
0.16% 73
2025
Q1
$594K Buy
719
+2
+0.3% +$1.66K 0.19% 62
2024
Q4
$554K Sell
717
-483
-40% -$400K 0.18% 59
2024
Q3
$1.06M Buy
1,200
+82
+7% +$73.7K 0.38% 30
2024
Q2
$1.01M Sell
1,118
-45
-4% -$36K 0.4% 28
2024
Q1
$905K Sell
1,163
-713
-38% -$507K 0.37% 28
2023
Q4
$1.09M Hold
1,876
0.41% 35
2023
Q3
$1.01M Sell
1,876
-100
-5% -$51.5K 0.4% 36
2023
Q2
$927K Sell
1,976
-100
-5% -$41.9K 0.35% 46
2023
Q1
$713K Buy
2,076
+388
+23% +$131K 0.28% 58
2022
Q4
$315K Buy
1,688
+5
+0.3% +$1.77K 0.14% 102
2022
Q3
$544K Sell
1,683
-67
-4% -$21.2K 0.26% 66
2022
Q2
$567K Buy
1,750
+38
+2% +$11.4K 0.26% 73
2022
Q1
$490K Buy
1,712
+8
+0.5% +$2.06K 0.19% 85
2021
Q4
$471K Buy
+1,704
New +$432K 0.17% 94
2021
Q2
$387K Sell
1,687
-1
-0.1% -$201 0.15% 97
2021
Q1
$315K Buy
1,688
+383
+29% +$74.9K 0.14% 102
2020
Q4
$220K Sell
1,305
-220
-14% -$32.8K 0.13% 123
2020
Q3
$226K Sell
1,525
-520
-25% -$80.5K 0.15% 113
2020
Q2
$336K Buy
2,045
+418
+26% +$64.2K 0.24% 88
2020
Q1
$214K Hold
1,627
0.16% 115
2019
Q4
$214K Buy
+1,627
New +$189K 0.16% 115

Other funds holding LLY

CWS Financial Advisors's LLY Position: Q1 2026 in Review

CWS Financial Advisors increased its Eli Lilly (LLY) stake by 54% in Q1 2026, buying an estimated $269K and bringing the position to 758 shares worth $697K. The position accounts for 0.18% of the portfolio, ranked #76.

CWS Financial Advisors first reported a position in LLY in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.09M in Q4 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • CWS Financial Advisors held 758 shares of Eli Lilly worth $697K as of Q1 2026.
  • CWS Financial Advisors bought 265 Eli Lilly shares in Q1 2026, an estimated $269K.
  • Eli Lilly made up 0.18% of CWS Financial Advisors's portfolio in Q1 2026, its #76 holding.
  • CWS Financial Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 25 quarters since.
  • CWS Financial Advisors's Eli Lilly position peaked at $1.09M in Q4 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on CWS Financial Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.